International Delphi Study to Develop Standardized Quality Criteria and a Rating Tool for Liver CEUS Image Quality Assessment (ICON LiverCEUS)
Delphi Study on Quality Indicators for CEUS Imaging of the Liver Using SonoVue® Contrast Agent
This study aims to establish international consensus-based quality criteria for contrast-enhanced ultrasound (CEUS) examinations of the liver and to develop a standardized tool for assessing CEUS image quality. CEUS is an established imaging technique used in clinical practice for the characterization and assessment of focal liver lesions and other liver abnormalities. Despite its increasing use, there are currently no universally accepted or validated standards for evaluating the quality and reproducibility of CEUS examinations.
The primary objective of this project is therefore to identify robust and clinically relevant quality indicators for liver CEUS examinations through an international Delphi consensus process. The study focuses specifically on CEUS examinations performed in adult patients using the ultrasound contrast agent SonoVue®.
The project is divided into two work packages (WP). In Work Package 1 (WP1), the study team will first conduct a structured review of the available literature and discuss potential CEUS quality criteria within the research group. Based on this process, an initial catalogue of quality indicators relating to technical, procedural, and imaging characteristics relevant to liver CEUS examinations will be developed.
These proposed criteria will subsequently be evaluated through a multi-round Delphi process involving an international and interdisciplinary panel of experienced CEUS users and experts. A minimum of 20 panellists will participate across all Delphi rounds. Participants will rate their level of agreement with each proposed quality criterion using a 7-point Likert scale and may suggest additional criteria where appropriate. Newly proposed criteria supported by more than 10% of participants will be included in subsequent Delphi rounds.
During each round, panellists will receive anonymised feedback summarising the responses of the group and will be invited to re-evaluate the relevance of the proposed criteria. This iterative process will continue for at least three rounds or until predefined consensus criteria are achieved. Consensus will be defined as at least 70% agreement with a rating of 6 or higher on the Likert scale.
In Work Package 2 (WP2), the consensus-based quality criteria identified in WP1 will be operationalised into a comprehensive and standardized rating scale for CEUS image quality assessment. Individual criteria will be grouped into broader domains and transformed into practical assessment items and prompts. The resulting rating tool will then be circulated among all Delphi panel members for final review and feedback to ensure clarity, applicability, and international usability.
The overall goal of this study is to improve standardization, quality assurance, and reproducibility in liver CEUS examinations. The developed consensus criteria and rating scale may support clinical practice, future research studies, multicentre collaborations, and educational initiatives by enabling more consistent evaluation of CEUS image quality across institutions and countries.
研究概览
详细说明
Contrast-enhanced ultrasound (CEUS) is an established and widely used imaging modality for the evaluation of focal liver lesions and other hepatic abnormalities. It plays an increasingly important role in clinical diagnostics due to its real-time imaging capability, safety profile, and broad availability. Despite its clinical relevance, there is currently no internationally standardised definition of adequate CEUS image quality, and no validated criteria exist for its objective assessment. As a result, interpretation and perceived diagnostic quality of CEUS examinations may vary considerably between operators, institutions, and healthcare systems.
The aim of this study is to develop internationally agreed, consensus-based quality criteria for adequate CEUS image quality in liver examinations and to translate these criteria into a standardised rating tool. The overall objective is to improve the reproducibility, comparability, and standardisation of CEUS examinations in both clinical practice and research settings.
To achieve this, the study is structured into two work packages (WP). Work Package 1 (WP1) focuses on identifying and refining relevant quality criteria for CEUS of the adult liver through an international Delphi consensus process.
Work Package 2 (WP2) focuses on clustering the agreed criteria into overarching domains and developing a structured rating scale for practical application.
In WP1, a preliminary set of potential quality indicators will be generated based on a structured literature review and expert discussion within the study team. These indicators will reflect technical, procedural, and image-related aspects of liver CEUS examinations. The most commonly applied CEUS context, adult liver imaging, will serve as the clinical focus of the study. An international panel of CEUS experts will be recruited based on defined expertise criteria, including extensive clinical experience in ultrasound and CEUS, training involvement, and scientific contribution to the field. Approximately 35 experts will be invited to participate in the first Delphi round, with an expected final panel size of at least 20 participants across all rounds.
The Delphi process will consist of three iterative survey rounds. In each round, participants will rate their agreement with predefined statements describing potential quality criteria using a 7-point Likert scale ranging from "completely disagree" to "completely agree," with an additional option for "outside of my expertise." Participants may also suggest additional criteria in the first round. Free-text responses will be systematically analysed, categorised, and included in subsequent rounds if supported by at least 10% of participants.
After each round, anonymised aggregated feedback will be provided to participants, including summary statistics such as median scores, interquartile ranges, and agreement rates. Participants will then be asked to reconsider and, if appropriate, revise their ratings in light of group responses. Consensus will be defined a priori as at least 70% of panellists rating a criterion as "agree" or "completely agree." Criteria not reaching consensus after repeated rounds will be revised or excluded according to predefined rules.
WP2 will translate the final consensus-based criteria into a structured rating scale for assessing CEUS image quality. The agreed criteria will be organised into overarching domains reflecting key dimensions of image quality. Within each domain, individual criteria will serve as structured prompts to guide evaluation. The resulting scale will be designed to be practical and reproducible and will use a simplified scoring system for domain-level assessment. Depending on the Delphi findings, non-imaging or technical aspects may be included as a separate domain.
The draft rating scale will be reviewed by the Delphi panel participants who completed all rounds. They will be asked to evaluate agreement with each domain and with the overall structure of the scale using a structured binary response format, with optional qualitative feedback. If predefined acceptance thresholds are not met, an additional revision round will be conducted.
Data analysis will include descriptive statistics for each criterion, including median and interquartile range, as well as calculation of agreement proportions. Responses indicating "outside of my expertise" will be treated as missing data and excluded from statistical calculations. Criteria will be evaluated against predefined consensus thresholds to determine inclusion, revision, or exclusion across Delphi rounds.
The final outcome of this study will be an internationally derived consensus set of quality criteria for liver CEUS examinations and a structured, standardised rating tool for assessing CEUS image quality. This framework is intended to support improved quality assurance, enhance reproducibility, and facilitate harmonisation of CEUS practice across institutions and countries in both clinical and research contexts.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Robin Walter, MD
- 电话号码:+41 79 844 71 34
- 邮箱:robin.walter@unibe.ch
研究联系人备份
- 姓名:Fabian M Föhrenbacher, MD
- 电话号码:+41 78 313 77 08
- 邮箱:fabi.foehri@web.de
学习地点
-
-
Canton of Bern
-
Bern、Canton of Bern、瑞士、3007
- 招聘中
- University of Bern
-
接触:
- Robin Walter, MD
- 电话号码:+41 79 844 7134
- 邮箱:robin.walter@unibe.ch
-
首席研究员:
- Robin Walther, MD
-
副研究员:
- Michael Harris, MD et MME
-
副研究员:
- Christoph Dietrich, MD et Prof.
-
副研究员:
- Fabian Föhrenbacher, MD
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
The study population consists of internationally recognised CEUS experts from radiology and internal medicine with extensive clinical and scientific experience in ultrasound diagnostics. Participants are recruited from multiple countries to form an interdisciplinary expert panel.
Inclusion requires expertise comparable to DEGUM Level III, including substantial ultrasound experience, regular performance of CEUS examinations, and involvement in CEUS training and/or research.
Approximately 35 experts will be invited for the first Delphi round, with at least 20 expected to complete all rounds. The purposive sampling approach ensures a highly specialised panel aimed at achieving expert consensus rather than statistical representativeness.
描述
Inclusion Criteria:
- At least 6 years of active experience in ultrasound diagnostics in internal medicine, radiology, or a related clinical field
- Independent performance of at least 5,000 ultrasound examinations Participation in structured CEUS training
- Performance of at least 800 ultrasound examinations per year in routine clinical practice
- Either: at least 100 independently performed CEUS examinations per year or more than 700 CEUS examinations in total
- Regular participation in ultrasound-related meetings, case reviews, or quality assurance activities within their institution
- Scientific involvement in CEUS, demonstrated by at least one peer-reviewed publication and/or active engagement in CEUS education or training
- Signing the consent form of the participants
Exclusion Criteria:
- Failure to meet the inclusion criteria
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
How many proposed contrast-enhanced ultrasound (CEUS) quality criteria achieve expert consensus, defined as ≥70% of panellists assigning a score of 6 ("agree") or 7 ("completely agree") on a 7-point Delphi Likert scale, by the end of Round 3?
大体时间:Completion of Delphi Round 3 (within six months)
|
The number of proposed CEUS quality criteria that achieve predefined consensus after completion of the Delphi process. Consensus is defined as ≥70% of participating experts assigning a score of 6 ("agree") or 7 ("completely agree") on a 7-point Likert scale evaluating the statement: "This criterion indicates adequate quality of a CEUS examination." The rating is based on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). Higher scores indicate stronger agreement that the criterion reflects adequate CEUS image quality. |
Completion of Delphi Round 3 (within six months)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
What percentage of experts assigns a score of 6 or 7 on the 7-point Delphi Likert scale to each proposed CEUS quality criterion across the Delphi rounds?
大体时间:After each Delphi round (within six months)
|
For each proposed quality criterion, the percentage of participating experts assigning a rating of 6 ("agree") or 7 ("completely agree") on the 7-point Likert scale will be calculated and reported. The rating is based on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). Higher scores indicate stronger agreement that the criterion reflects adequate CEUS image quality. |
After each Delphi round (within six months)
|
|
What are the median ratings for each proposed CEUS quality criterion on the 7-point Delphi Likert scale across the Delphi rounds?
大体时间:After each Delphi round (within six months)
|
Median expert rating for each proposed CEUS quality criterion. Responses marked as "Outside of my expertise" will be excluded from calculation. The rating is based on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). Higher scores indicate stronger agreement that the criterion reflects adequate CEUS image quality. |
After each Delphi round (within six months)
|
|
What are the interquartile ranges (IQRs) of expert ratings for each proposed CEUS quality criterion on the 7-point Delphi Likert scale across the Delphi rounds?
大体时间:After each Delphi round (within six months)
|
Interquartile range (IQR) of expert ratings for each proposed CEUS quality criterion. Lower IQR values indicate greater agreement among panellists. The rating is based on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). Higher scores indicate stronger agreement that the criterion reflects adequate CEUS image quality. |
After each Delphi round (within six months)
|
|
How many quality domains are incorporated into the final CEUS image quality rating scale derived from the consensus-based criteria?
大体时间:Following completion of Work Package 2 (within six months)
|
Total number of domains derived from consensus-based CEUS quality criteria and incorporated into the final rating scale developed in Work Package 2.
|
Following completion of Work Package 2 (within six months)
|
|
What percentage of Experts Approving the Final Contrast-Enhanced Ultrasound Image Quality Rating Scale Using Binary Agreement Responses?
大体时间:Final rating scale evaluation survey (within six months)
|
Percentage of Delphi panellists who completed all Delphi rounds and respond "Yes" to the question: "Do you agree this rating scale covers the important aspects to rate adequate CEUS image quality?" The survey is conducted using a binary response scale (Yes/No). Higher percentages indicate greater acceptance of the final rating scale. |
Final rating scale evaluation survey (within six months)
|
合作者和调查者
调查人员
- 学习椅:Robin Walter、University of Bern
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- Delphi on CEUS: Req-2025-01086
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.